Coastal Bridge Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
APM
Coastal Bridge Advisors's ARKG Position: Q2 2022 in Review
Coastal Bridge Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,838 shares — an estimated $268K sold.
Coastal Bridge Advisors first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $591K in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.
- Coastal Bridge Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
- Coastal Bridge Advisors sold 5,838 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $268K.
- Coastal Bridge Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
- Coastal Bridge Advisors's ARK Genomic Revolution ETF position peaked at $591K in Q2 2021.
- 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.
Based on Coastal Bridge Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.